Recent Finacing
Recent Raise
Neogene develops personalized engineered T cell therapies by isolating neoantigen-specific TCRs via sequencing, synthesis and screening, then engineering them into patient T cells without tumor material.
Focus Areas
Recent Investors
Funding round
Investors